Voyager Acquisition Corp.
corporate_fare Company Profile
Voyager Acquisition Corp. (NASDAQ:VACH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for VACH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-29, rated 9/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for VACH spans 8-K, 10-Q.
Recent high-impact activity:
- Voyager Acquisition Secures $27.5M in Secured Notes, $50M Equity Facility to Address Liquidity Crisis
- Voyager Acquisition Secures $29.56M in Secured Notes & Warrants, Establishes $50M ATM Program Amid Liquidity Crisis
- Voyager Acquisition Corp. Issues Going Concern Warning Amidst Near-Total Share Redemptions
- Shareholders Approve Veraxa Biotech Merger Amidst 99.67% Share Redemptions
- Voyager Acquisition Secures Final Approval for Veraxa Biotech Merger
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for VACH, detected from its recent SEC filings.
Secured Private Placement · At-The-Market (ATM) Program Established
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →